2020201920182017201620152014 August 21, 2014 Summary ToggleSpero Therapeutics Announces Publication in PLoS Pathogens Describing Potential Strategy for Combating Resistant Gram-Negative Bacteria August 19, 2014 Summary ToggleSpero Therapeutics To Present Data on the Impact of Targeted MvfR-Regulon Inhibitors on Gram Negative Bacteria at Upcoming ICAAC Meeting May 19, 2014 Summary ToggleSpero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer April 09, 2014 Summary ToggleSpero Formed to Develop First-in-Class Therapeutics for Drug-Resistant Bacterial Infections Pagination First page First Previous page Previous … Page 11 Page 12 Page 13 Current page 14
